Caleres beat Q2 EPS and sales estimates and raised FY26 EPS guidance, and its shares jumped on that news.
Caleres reported Q2 EPS of $0.47 and sales of $695.454 million, both above analyst estimates, and it raised FY26 EPS guidance. The company’s report and guidance lifted its shares sharply, so I read the news as positive for Caleres.
Sunbelt reported better-than-expected Q1 results and raised FY27 sales guidance, and its shares rose.
Opus Genetics announced positive early trial results and its shares jumped sharply on the update.
Flotek raised its 2026 guidance and the stock surged on the news.
Signet reported better-than-expected Q2 results and raised FY27 adjusted EPS guidance, sending the stock higher.
Oddity Tech beat Q2 results and issued Q3 and FY26 sales guidance above estimates, lifting its shares.
Follow Caleres Inc (CAL) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CAL